Gates Foundation Forms an Alliance with Global Pharma Companies to Develop PAN-TB Drug Regimen for Tuberculosis

Shots:

• GSK, Evotec, J&J, Otsuka, the Bill & Melinda Gates Medical Research Institute and its foundation have launched the ‘PAN-TB collaboration’ project to collaboratively accelerate the development of novel TB treatment regimens
• The global collaboration will focus on developing a new regimen with the drug candidates that demonstrated efficacy in its P-II studies with limited or no drug resistance to achieve the global eradication of the disease
• The PAN-TB collaboration is a first-of-its-kind collaboration among philanthropic, non-profit and private sectors to facilitate the development of an investigational drug regimen for treating all forms of TB

Click here ­to­ read full press release/ article | Ref: GSK | Image: Infectious Disease Advisor